Ramalingam Sathishkumar, Arora Harkesh, Gunasekaran Kulothungan, Muruganandam Maheswari, Nagaraju Sivakumar
Hospital Medicine, Lovelace Medical Center, Albuquerque, USA.
Pulmonary Critical Care, Yale New Haven Health Bridgeport Hospital, Bridgeport, USA.
Cureus. 2021 Jan 22;13(1):e12856. doi: 10.7759/cureus.12856.
In general, upper extremity deep vein thrombosis (DVT) is less common than lower extremity DVT. Among upper extremity DVT cases, most of them are due to secondary causes like indwelling catheters, cancer, surgery, trauma or immobilization by plaster casts, pregnancy, oral contraceptives, and estrogen. Patients with coronavirus disease 2019 (COVID-19) infection are known to have coagulation dysfunction and a high incidence of DVT, mostly in the lower extremities; however, upper extremity DVT has been rarely reported. We present a rare case of upper extremity DVT in COVID-19 infection. A 56-year-old male with no significant past medical history was admitted with acute respiratory failure due to COVID-19 pneumonia. During hospitalization, he developed right upper extremity swelling, and an ultrasonogram showed right radial vein thrombosis. He was initially started on low molecular weight heparin (LMWH) and was discharged on apixaban. Patients with COVID-19 infection who develop DVT are recommended treatment with a direct oral anticoagulant (DOAC) for three months.
一般来说，上肢深静脉血栓形成（DVT）比下肢DVT少见。在上肢DVT病例中，大多数是由诸如留置导管、癌症、手术、创伤或石膏固定制动、妊娠、口服避孕药和雌激素等继发原因引起的。已知2019冠状病毒病（COVID-19）感染患者存在凝血功能障碍且DVT发病率高，大多发生在下肢；然而，上肢DVT鲜有报道。我们报告1例COVID-19感染合并上肢DVT的罕见病例。一名56岁男性，既往无重大病史，因COVID-19肺炎导致急性呼吸衰竭入院。住院期间，他出现右上臂肿胀，超声检查显示右桡静脉血栓形成。他最初开始使用低分子量肝素（LMWH）治疗，出院时服用阿哌沙班。建议COVID-19感染合并DVT的患者使用直接口服抗凝剂（DOAC）治疗3个月。
